Regional News

Cangzhou Thrives via Grand Canal and Intangible cultural heritage Preservation

CANGZHOU, China, Jan. 23, 2024 /PRNewswire/ -- Nanchuan Building and Langyin Building, two historic buildings beside the Beijing-Hangzhou Grand Canal in Cangzhou,North China's Hebei Province, officially opened to the public recently. To rev...

2024-01-24 03:08 1595

CASETiFY launches Impact Ring Stand, Clear & Mirror Cases for Samsung Galaxy S24 Series

The most comprehensive Samsung Galaxy accessory lineup from CASETiFY to date combines functionality with superb design LOS ANGELES, Jan. 23, 2024 /PRNewswire/ -- Minutes after the Samsung Galaxy Unpacked Event, global tech accessory brand CASETiFY has launchedits newest lineup of tech accessorie...

2024-01-24 02:58 1427

Allxon Collaborates with NVIDIA to Deploy Generative AI at the Industrial Edge

Combining Powerful Fleet Management with Modern AI Software Stacks and Development Workflows through NVIDIA Metropolis Microservices for Jetson  TAIPEI, Jan. 23, 2024 /PRNewswire/ -- Allxon today announced a collaborative effort with NVIDIA to help manage fleets ofNVIDIA Jetson O

2024-01-24 02:00 1383

Coway Expands Cutting-Edge Air Purifier Product Line With Launch of Affordable, Cylindrical Model for Small Spaces: The Airmega 100

First Airmega With 360° Air Intake Turns Cozy Areas Into Wellness Sanctuaries With Robust, 3-Stage, HEPA Air Filtration System LOS ANGELES, Jan. 23, 2024 /PRNewswire/ -- Coway , a leading wellness tech company, today launched theAirmega 100

2024-01-24 02:00 1435

Baidu Global MediaGo Announces Collaboration with Amazon Publisher Services

Through the collaboration, publishers will have the opportunity to bring diverse, incremental demand to their advertising inventory. SUNNYVALE, Calif., Jan. 23, 2024 /PRNewswire/ -- MediaGo, a deep learning-based intelligent advertising platform under the Baidu Global Business Unit, today announ...

2024-01-24 00:00 1353

Datasea Pre-Announces First Half 2024 Revenue of $18.2 Million, a 1,037.5% Year-Over-Year Increase

BEIJING, Jan. 23, 2024 /PRNewswire/ -- Datasea Inc., (NASDAQ: DTSS) ("Datasea" or the "Company"), aNevada incorporated digital technology corporation engaged in converging and innovative business segments for intelligent acoustics and 5G messaging technology inChina pre-announced that its revenue...

2024-01-23 22:35 3020

Rhino Rescue Speeds into the Future of First-Aid Supplies with New Year Resolutions for 2024

Propelling Lifesaving Measures with User-friendly Innovations in 2024 SHANGHAI, Jan. 23, 2024 /PRNewswire/ -- As the New Year unfolds, Rhino Rescue , a global innovator in premier first-aid supplies, would like to take a moment to reflect upon and celebrate its rem...

2024-01-23 22:15 1470

LILYSILK Unveils 'A Laidback Luxe' Spring 2024 Collection, Blending Californian Casual with Hollywood Glamour

NEW YORK, Jan. 23, 2024 /PRNewswire/ -- LILYSILK , the world's leading silk brand with a mission to inspire people to live spectacular, sustainable lives, is thrilled to unveil its Spring 2024 Collection, "A Laidback Luxe." Launching onJanuary 21st, the Collection is a ...

2024-01-23 22:00 1292

Goodman's digital infrastructure offering powers ahead with data centre expansion in Asia

Key points: * Commenced infrastructure works for an available 1,000 MW of power at a new data centre campus in Tsukuba City,Greater Tokyo, Japan * Entered into a Heads of Agreement with a customer to lease the first 50 MW data centre to be developed at Goodman's new Tsukuba campus * ...

2024-01-23 22:00 2027

Akeso Presented Promising Results of Cadonilimab and Lenvatinib in Combination with TACE in uHCC at 2024 ASCO GI

HONG KONG, Jan. 23, 2024 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso," "we," or the "Company") today announced that the Company presented the promising phase II results of cadonilimab (a tetravalent PD-1/CTLA-4 bispecific antibody) and Lenvatinib (Len) combined with TACE for the treatment of mi...

2024-01-23 21:00 2870

Greenland Technologies Announces Amerit Fleet Solutions has Joined HEVI's Approved Service Provider Network Program

EAST WINDSOR, NJ., Jan. 23, 2024 /PRNewswire/ -- Greenland Technologies Holding Corporation (Nasdaq: GTEC) ("Greenland" or the "Company"), a technology developer and manufacturer of electric industrial vehicles and drivetrain systems for material handling machineries and vehicles, today announced...

2024-01-23 21:00 1156

MDJM LTD Issues Letter to Shareholders Regarding Strategic Focus and Progress in UK Market Initiatives

LETHAM, Scotland, Jan. 23, 2024 /PRNewswire/ -- MDJM LTD (Nasdaq: MDJH) (the "Company" or "MDJM"), an integrated global culture-driven asset management company, today issued the following letter to shareholders from its Chairman and CEO,Siping Xu, providing an update on the Company's strategic sh...

2024-01-23 20:30 2162

Jayud Announces Entry into Agreements to Acquire Two International Logistics Companies, Embarking on an Acquisition Strategy to Expand Service Offerings and Geographic Footprint

SHENZHEN, China, Jan. 23, 2024 /PRNewswire/ -- Jayud Global Logistics Limited (NASDAQ: JYD) ("Jayud" or the "Company"), a leading end-to-end supply chain solution provider based inShenzhen, specializing in cross-border logistics, today announced that Shenzhen Jayud Logistics Technology Co., Ltd.,...

2024-01-23 20:30 3041

ChipMOS SCHEDULES FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS CONFERENCE CALL

HSINCHU, Jan. 23, 2024 /PRNewswire-FirstCall/ -- ChipMOS TECHNOLOGIES INC. ("ChipMOS" or the "Company") (Taiwan Stock Exchange:8150 and NASDAQ: IMOS), an industry leading provider of outsourced semiconductor assembly and test services ("OSAT"),...

2024-01-23 19:00 1110

Caliway Received First Approval of CBL-514 Pivotal Phase 3 Study Application for Subcutaneous Fat Reduction

NEW TAIPEI CITY, Jan. 23, 2024 /PRNewswire/ -- Caliway Biopharmaceuticals (Caliway) announces that Australian Bellberry HREC has approved Caliway's application to initiate CBL-514's Pivotal Phase 3 study (CBL-0301 Phase 3) for subcutaneous fat reduction. "We are all delighted to see CBL-514 show...

2024-01-23 18:35 1062

Baird Medical Performs First Thyroid Microwave Ablation Procedure in the United States

FRISCO, Texas, Jan. 23, 2024 /PRNewswire/ -- Baird Medical Devices, Inc. ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider inChina and the United States, today announced that it has performed its first thyroid MWA procedure inthe United...

2024-01-23 18:00 1149

Global Times: Uzbekistan seeking new path to progress and prosperity with China

BEIJING, Jan. 23, 2024 /PRNewswire/ -- The year 2023 has been a busy one for China in terms of its interactions with the rest of the world. Its foreign relations always have a profound impact on its economy, strategy and people's livelihoods. Global Times, in collaboration withChina's universitie...

2024-01-23 17:42 1130

Airoha Technology GNSS Chip Series Have been Tested and Qualified in accordance with AEC-Q100 Grade 2

HSINCHU, Jan. 23, 2024 /PRNewswire/ -- Airoha Technology specializing on fixed broadband network infrastructure and advanced Artificial Intelligence of Things, launched the AG3335MA satellite positioning chip series in the end of December 2023, which has passed the AEC-Q100 Grade 2 reliability qua...

2024-01-23 14:00 1269

GMCC & Welling Ignite AHR Expo 2024 with One-Stop Full-Scenario HVAC and Refrigeration Solutions

CHICAGO, Jan. 22, 2024 /PRNewswire/ -- GMCC & Welling showcased their comprehensive portfolio and solutions in AHR Expo 2024 inChicago, United States that with a full scenario coverage of residential air conditioners, commercial air conditioners, heat pump air conditioners, heat pump water heater...

2024-01-23 13:07 1185

European Medicines Agency (EMA) Grants Orphan Drug Designation (ODD) to GC Biopharma's Treatment for Sanfilippo Syndrome (Type A)

YONGIN, South Korea, Jan. 22, 2024 /PRNewswire/ -- GC Biopharma Corp. (006280.KS) announced that the European Medicines Agency (EMA) has granted Orphan Drug Designation (ODD) to its intracerebroventricular (ICV) Enzyme Replacement Therapy (ERT) candidate, GC1130A, designed for Sanfilippo Syndrome...

2024-01-23 11:53 1285